Expansion Adds U.S. FDA and EU Annex 1 Compliant GMP Capacity with High-Throughput Manufacturing Design and Advanced Automation by Q3 2026. "As more therapies advance to late-stage development, the ...
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Cellistic®, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing, announces the successful audit and GMP certification of its ...
MINNEAPOLIS, Dec. 20, 2023 /PRNewswire/ -- Bio-Techne Corporation (TECH) today announced that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for its ...
Made Scientific, a leading clinical and commercial-enabling cell therapy contract development and manufacturing organization (CDMO), and Streamline Bio, a next-generation autonomous robotics company ...
Combining cell and gene therapeutic approaches is reshaping basic and translational research, yielding new models and tools that help scientists delve deeper into the drivers of health and disease.
Made Scientific marked a milestone Aug. 13 as it cut the ribbon on its new cell therapy manufacturing facility and headquarters in Princeton. A number of government officials, industry leaders and ...
Lonza Group AG has broadened its suite of CGT manufacturing solutions with 2 new products: TheraPEAK AmpliCell Cytokines and ...
"We're not a one-size-fits-all CDMO," said Min Park, CCO of Matica Bio. "Our team works closely with each partner to deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback